Navigation Links
Par Pharmaceutical Reports Third-Quarter 2007 Results
Date:12/20/2007

d in addition to, and not in lieu of, U.S. GAAP financial measures. The Company's non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward- looking and, as such, are subject to risks and uncertainties, including the extent and impact of litigation arising out of the accounting issues described in the Company's filings with the Securities and Exchange Commission (SEC), the difficulty of predicting FDA filings and approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, uncertainty of patent litigation filed against the Company, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks and uncertainties detailed from time to time in the Company's filings with the SEC, such as the Company's reports on Form 10-K, Form 10-Q and Form 8-K, and amendments thereto. Any forward-looking statements included in this press release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.

PAR PHARMACEUTICAL COMPANIES, INC.


'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... published in this week,s JAMA highlights the ... when considering how to treat patients. Written by Robert ... and chair of pediatrics at Boston University School of ... , the editorial examines results of a study published ... example of how doctors can often over-emphasize certain types ...
(Date:8/19/2014)... Recently, UWDress.com, a professional company of women’s ... plus size formal evening dresses . Additionally, the firm ... outfits. At the moment, all of them can be ordered ... will be valid until August 27, 2014. , The ... top designers believe that women of all shapes can be ...
(Date:8/19/2014)... Horizon Blue Cross Blue Shield of New Jersey ... again teaming up during The Barclays at The Ridgewood ... Challenge, and Horizon BCBSNJ will be getting spectators into the ... their own. , Horizon BCBSNJ, the official health care sponsor ... donation to the New Jersey Golf Foundation, an organization that ...
(Date:8/19/2014)... ME (PRWEB) August 19, 2014 Drews Dental ... J. Drews, D.D.S., to vice president of the Maine Dental ... MDA for three years, Dr. Drews has now been sworn ... forward to serving his term as vice president and being ... as well as the First District Caucus in 2015. He ...
(Date:8/19/2014)... smoke during their stay and could use this time as ... smoke-free after returning home. Now a study published in ... program that increased the proportion of hospitalized smokers who successfully ... The system used interactive voice response technology automated telephone ... months after smokers left the hospital. , "Most ...
Breaking Medicine News(10 mins):Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Cheap Plus Size Formal Evening Dresses Announced By UWDress.com 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 3Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 4Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2
... , , , ... the U.S. Food and Drug Administration (FDA) has approved a 3000 ... factor (recombinant). The new vial size offers greater convenience for ... , The 3000 IU vial may eliminate the need ...
... , NEW YORK, Aug. 7 President Bill ... Yancy, president of the American Heart Association and Dr. ... the Fourth Annual Healthy Schools Program Forum in New York to honor 114 ... to learn and staff to work. , , "As kids ...
... , ARDEE, Ireland, Aug. 7 /PRNewswire-Firstcall/ ... its results for the quarter ended June 30, 2009. Revenue in ... over the prior year quarter. The primary drivers of the increase ... and ESTRACE Cream which were partially offset by net sales declines ...
... , LOS ANGELES, Aug. 7 "August marks ... comments Susan, mother of five and teacher who recalls living with ... next you,d have thought Satan walked through the door." , ... *(Photo Caption/Cutline: Mother with drug-free daughter, a Narconon graduate.) , ...
... ... RN, MBA, CMRP, as vice president for consulting. , ... St. Louis, MO (Vocus) -- Navvis & ... consulting. Cleveland brings to the firm and its clients extensive experience and expertise in ...
... Carnegie Mellon University have developed an analytical technique ... to complex disease syndromes such as diabetes, asthma ... and molecular traits. , Rather than searching one ... a particular symptom or trait, as in ...
Cached Medicine News:Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 2Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 3Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 4Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 2Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 3Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 4Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 18Health News:Mother & Daughter Celebrate Victory Over 'Meth' 2Health News:Cleveland Joins Navvis & Company 2Health News:Carnegie Mellon develops innovative method to detect genetic causes of complex diseases 2
(Date:8/19/2014)... Aug. 19, 2014  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ... , Sanofi and Regeneron will host an IR Thematic ... Tuesday, September 2, 2014 , Baird 2014 Healthcare ... 3, 2014 , Citi,s 9 th Annual ... September 4, 2014 , Morgan Stanley Global Healthcare ...
(Date:8/19/2014)... Colo. , Aug. 19, 2014 ... Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), ... rd Annual Meeting of the American Academy ... Acute Care Surgery in Philadelphia, Pennsylvania ... 2014.  The presentation will report results from a ...
(Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9
... China , July 9 /PRNewswire-Asia-FirstCall/ -- ... or the "Company"), a,developer, manufacturer and distributor of ... announced,that on July 8, 2010 , the ... Red Star Forest Bureau of Heilongjiang Province ...
... ATHENS, Greece , July 9 The companies ... and translator of the Greek language version of the GeneMedRx ... the program will include hundreds of drugs used exclusively in ... Greek language graphical user interface. Both the English and Greek ...
Cached Medicine Technology:Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 2Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 3Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 4Medigene Appointed Exclusive Greek Licensee for GeneMedRx Personalized Prescribing Software 2
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Open 11 mm blades. Dull finish. Most popular size or model....
Open 5 mm blades. Dull finish. Most popular size or model....
Closed wire 5 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Medicine Products: